TrademarkDir
RAZTAMRI
DEAD

Serial Number

97855551

Owner

SYROS Pharmaceuticals, Inc.

Attorney

Ann Lamport Hammitte

Filing Date

Mar 24, 2023

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

RAZTAMRI Trademark

Serial Number: 97855551

RAZTAMRI is a trademark filed by SYROS Pharmaceuticals, Inc. on March 24, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

SYROS Pharmaceuticals, Inc.

35 CambridgePark Drive, 4th Floor
Cambridge, MA 02140

Entity Type: 03

Trademark Details

Filing Date

March 24, 2023

Registration Date

Not Registered

Published for Opposition

December 3, 2024

Goods & Services

pharmaceutical products for the treatment of hematologic cancers; pharmaceuticals for treatment of a myelodysplastic syndrome; pharmaceuticals for treatment of acute myeloid leukemia, which is also known as acute myelogenous leukemia and acute nonlymphocytic leukemia

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 18, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 18, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 14, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 27, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 8, 2024 CNSA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 8, 2024 ZZZX
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 6, 2024 JURT
PETITION TO DIRECTOR GRANTED
Aug 6, 2024 PCGR
ASSIGNED TO PETITION STAFF
Aug 2, 2024 APET
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
May 22, 2024 ISPO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2024 PUBO
TEAS PETITION TO DIRECTOR RECEIVED
May 7, 2024 TPDR
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 10, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 10, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 10, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 10, 2024 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 24, 2023 GNRN
NON-FINAL ACTION E-MAILED
Dec 24, 2023 GNRT
NON-FINAL ACTION WRITTEN
Dec 24, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 19, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2023 NWOS
NEW APPLICATION ENTERED
Mar 28, 2023 NWAP

Related Trademarks